×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
HOLX – hologic, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
HOLX
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/2
08:10 am
holx
New Data to be Presented at the 2025 SABCS Demonstrates Potential Expanded Utility of the Breast Cancer Index Test, the Leading Biomarker in Personalizing Endocrine Therapy Duration
Low
Report
New Data to be Presented at the 2025 SABCS Demonstrates Potential Expanded Utility of the Breast Cancer Index Test, the Leading Biomarker in Personalizing Endocrine Therapy Duration
12/1
10:24 am
holx
Hologic, Inc. (HOLX) Is a Trending Stock: Facts to Know Before Betting on It [Yahoo! Finance]
Low
Report
Hologic, Inc. (HOLX) Is a Trending Stock: Facts to Know Before Betting on It [Yahoo! Finance]
11/25
08:08 am
holx
New Clinical Evidence on Hologic’s AI-Powered Mammography Solutions Will Be Unveiled at RSNA
Low
Report
New Clinical Evidence on Hologic’s AI-Powered Mammography Solutions Will Be Unveiled at RSNA
11/21
05:30 pm
holx
$HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Mergers-HOLX, MOFG, NIC, and AWK
Low
Report
$HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Mergers-HOLX, MOFG, NIC, and AWK
11/21
08:13 am
holx
Hologic (NASDAQ:HOLX) was downgraded by analysts at BNP Paribas Exane from an "outperform" rating to a "neutral" rating. They now have a $79.00 price target on the stock.
Low
Report
Hologic (NASDAQ:HOLX) was downgraded by analysts at BNP Paribas Exane from an "outperform" rating to a "neutral" rating. They now have a $79.00 price target on the stock.
11/21
06:04 am
holx
Hologic (NASDAQ:HOLX) was downgraded by analysts at BNP Paribas to a "neutral" rating.
Low
Report
Hologic (NASDAQ:HOLX) was downgraded by analysts at BNP Paribas to a "neutral" rating.
11/12
07:10 pm
holx
Hologic Introduces Digital Pathology Capabilities With Expanded CE Marking [Yahoo! Finance]
Low
Report
Hologic Introduces Digital Pathology Capabilities With Expanded CE Marking [Yahoo! Finance]
11/12
08:11 am
holx
Hologic Introduces Digital Pathology Capabilities With Expanded CE Marking
Low
Report
Hologic Introduces Digital Pathology Capabilities With Expanded CE Marking
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/18
04:33 pm
holx
Form 4 HOLOGIC INC For: Nov 14 Filed by: MACMILLAN STEPHEN P
Low
Report
Form 4 HOLOGIC INC For: Nov 14 Filed by: MACMILLAN STEPHEN P
11/18
04:31 pm
holx
Form 4 HOLOGIC INC For: Nov 14 Filed by: Verstreken Jan
Low
Report
Form 4 HOLOGIC INC For: Nov 14 Filed by: Verstreken Jan
11/18
04:29 pm
holx
Form 4 HOLOGIC INC For: Nov 14 Filed by: Schnittker Brandon
Low
Report
Form 4 HOLOGIC INC For: Nov 14 Filed by: Schnittker Brandon
11/18
04:28 pm
holx
Form 4 HOLOGIC INC For: Nov 14 Filed by: Schneiders Jennifer M
Low
Report
Form 4 HOLOGIC INC For: Nov 14 Filed by: Schneiders Jennifer M
11/18
04:26 pm
holx
Form 4 HOLOGIC INC For: Nov 14 Filed by: Oberton Karleen Marie
Low
Report
Form 4 HOLOGIC INC For: Nov 14 Filed by: Oberton Karleen Marie
11/18
04:22 pm
holx
Form 4 HOLOGIC INC For: Nov 14 Filed by: Mitchell Essex D
Low
Report
Form 4 HOLOGIC INC For: Nov 14 Filed by: Mitchell Essex D
11/18
04:17 pm
holx
Form 4 HOLOGIC INC For: Nov 14 Filed by: Liddy Anne M.
Low
Report
Form 4 HOLOGIC INC For: Nov 14 Filed by: Liddy Anne M.
11/18
04:14 pm
holx
Form 4 HOLOGIC INC For: Nov 14 Filed by: COHN BENJAMIN JORDAN
Low
Report
Form 4 HOLOGIC INC For: Nov 14 Filed by: COHN BENJAMIN JORDAN
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/19
CDC, public labs have conducted 37,824 COVID-19 tests [MarketWatch]
6.5%
3/18 CDC, public health labs have conducted at least 31,000 tests [MarketWatch] 5.8%
4/23 Hologic, Inc. (NASDAQ: HOLX) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. 5.1%
4/2 Hologic, Inc. (NASDAQ: HOLX) had its price target lowered by analysts at Needham & Company LLC from $62.00 to $52.00. They now have a "buy" rating on the stock. 4.8%
4/8 Hologic, Inc. (NASDAQ: HOLX) had its "outperform" rating re-affirmed by analysts at William Blair. 4.7%
11/20 Clayton, Dubilier & Rice to Acquire Market-Leading Medical Aesthetics Technology Company 4.3%
3/9 Form 4 HOLOGIC INC For: Mar 05 Filed by: HANTSON LUDWIG 4.0%
4/7 Form 8-K HOLOGIC INC For: Apr 07 2.9%
3/26 Hologic, Inc. (NASDAQ: HOLX) had its price target lowered by analysts at Barclays PLC from $51.00 to $43.00. They now have an "equal weight" rating on the stock. 2.8%
1/31 Hologic, Inc. (NASDAQ: HOLX) was upgraded by analysts at TheStreet from a "c" rating to a "b+" rating. 2.7%
3/18 CDC, public health labs have conducted at least 31,000 tests [MarketWatch] 5.8%
4/23 Hologic, Inc. (NASDAQ: HOLX) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. 5.1%
4/2 Hologic, Inc. (NASDAQ: HOLX) had its price target lowered by analysts at Needham & Company LLC from $62.00 to $52.00. They now have a "buy" rating on the stock. 4.8%
4/8 Hologic, Inc. (NASDAQ: HOLX) had its "outperform" rating re-affirmed by analysts at William Blair. 4.7%
11/20 Clayton, Dubilier & Rice to Acquire Market-Leading Medical Aesthetics Technology Company 4.3%
3/9 Form 4 HOLOGIC INC For: Mar 05 Filed by: HANTSON LUDWIG 4.0%
4/7 Form 8-K HOLOGIC INC For: Apr 07 2.9%
3/26 Hologic, Inc. (NASDAQ: HOLX) had its price target lowered by analysts at Barclays PLC from $51.00 to $43.00. They now have an "equal weight" rating on the stock. 2.8%
1/31 Hologic, Inc. (NASDAQ: HOLX) was upgraded by analysts at TheStreet from a "c" rating to a "b+" rating. 2.7%
TOP News Decliners
3/17
Form 8-K HOLOGIC INC For: Mar 16
-11.4%
3/11 Form 4 HOLOGIC INC For: Mar 09 Filed by: CRAWFORD SALLY -9.9%
4/30 Hologic, Inc. (NASDAQ: HOLX) had its price target raised by analysts at Needham & Company LLC from $52.00 to $60.00. They now have a "buy" rating on the stock. -8.1%
3/20 CDC, public health labs performed at least 44,000 COVID-19 tests [MarketWatch] -5.9%
11/7 Hologic, Inc. (HOLX) CEO Steve MacMillan on Q4 2019 Results - Earnings Call Transcript [Seeking Alpha] -5.3%
10/1 Hologic CEO Steve MacMillan to Ring Nasdaq Opening Bell on October 2 -4.5%
3/10 Form 8-K HOLOGIC INC For: Mar 05 -4.5%
8/14 Hologic, Inc. (NASDAQ: HOLX) had its price target raised by analysts at Argus to $62.00. They now have a "buy" rating on the stock. -4.4%
3/5 German Lab Demonstrates Feasibility to Detect SARS-Coronavirus-2 (SARS-CoV-2) Using Hologic’s Panther Fusion® System -4.3%
3/21 CDC, public health labs have tested at least 54,205 Americans for coronavirus [MarketWatch] -3.7%
3/11 Form 4 HOLOGIC INC For: Mar 09 Filed by: CRAWFORD SALLY -9.9%
4/30 Hologic, Inc. (NASDAQ: HOLX) had its price target raised by analysts at Needham & Company LLC from $52.00 to $60.00. They now have a "buy" rating on the stock. -8.1%
3/20 CDC, public health labs performed at least 44,000 COVID-19 tests [MarketWatch] -5.9%
11/7 Hologic, Inc. (HOLX) CEO Steve MacMillan on Q4 2019 Results - Earnings Call Transcript [Seeking Alpha] -5.3%
10/1 Hologic CEO Steve MacMillan to Ring Nasdaq Opening Bell on October 2 -4.5%
3/10 Form 8-K HOLOGIC INC For: Mar 05 -4.5%
8/14 Hologic, Inc. (NASDAQ: HOLX) had its price target raised by analysts at Argus to $62.00. They now have a "buy" rating on the stock. -4.4%
3/5 German Lab Demonstrates Feasibility to Detect SARS-Coronavirus-2 (SARS-CoV-2) Using Hologic’s Panther Fusion® System -4.3%
3/21 CDC, public health labs have tested at least 54,205 Americans for coronavirus [MarketWatch] -3.7%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: